Oncostatin M as a target biological molecule of preeclampsia

Journal of Obstetrics and Gynaecology Research

Volumn 35, Issue 5, 2009, Pages 869-875

  Lee, Guisera ^a   Kil, Gichul ^a   Kwon, Jiyoung ^a   Kim, Sajin ^a   Yoo, Jinyoug ^b   Shin, Jongchul ^a  

^a Departments of Obstetrics and Gynecology   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Oncostatin M; Placenta; Preeclampsia

Indexed keywords

ONCOSTATIN M;

ADULT; ANTIGEN ANTIBODY REACTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTROPHOBLAST; DISEASE SEVERITY; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FROZEN SECTION; GENE EXPRESSION; HUMAN; HYPOTHESIS; IMMUNOREACTIVITY; MOLECULAR BIOLOGY; PATHOLOGIST; PLACENTA; PREECLAMPSIA; PREGNANCY; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UMBILICAL VEIN;

EID: 70350469962     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2009.01114.x     Document Type: Article

References (26)

1. Lamarca BD, Ryan MJ, Gilbert JS, Murphy SR, Granger JP. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr Hypertens Rep 2007 9 : 480 485.
2. Casart YC, Tarrazzi K, Camejo MI. Serum levels of interleukin-6, interleukin-1beta and human chorionic gonadotropin in pre-eclamptic and normal pregnancy. Gynecol Endocrinol 2007 23 : 300 303.
3. Montagnana M, Lippi G, Albiero A, Salvagno GL, Franchi M, Guidi GC. Serum pro-inflammatory cytokines in physiological and pre-eclamptic pregnancies. Gynecol Endocrinol 2008 24 : 113 116.
4. Luppi P, Deloia JA. Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol 2006 118 : 268 275.
5. Rusterholz C, Hahn S, Holzgreve W. Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol 2007 29 : 151 162.
6. Ogata I, Shimoya K, Moriyama A et al. Oncostatin M is produced during pregnancy by decidual cells and stimulates the release of hCG. Mol Hum Reprod 2000 6 : 750 757.
7. Vasse M, Pourtau J, Trochon V et al. Oncostatin M induces angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol 1999 19 : 1835 1842.
8. Seo M, Kim A, Kim O et al. Differential gene expression profiling in placental tissue of severe preeclamptic and normal pregnancies using cDNA in microarray. Korean J Fetal Med 2007 3 : 246 253.
9. Borekci B, Aksoy H, Al RA, Demircan B, Kadanali S. Maternal serum interleukin-10, interleukin-2 and interleukin-6 in pre-eclampsia and eclampsia. Am J Reprod Immunol 2007 58 : 56 64.
10. Sharma A, Satyam A, Sharma JB. Leptin, il-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 2007 58 : 21 30.
11. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: Linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002 9 : 147 160.
12. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem J 2003 374 : 1 20.
13. Tanaka M, Miyajima A. Oncostatin M, a multifunctional cytokine. Rev Physiol Biochem Pharmacol 2003 149 : 39 52.
14. Ruprecht K, Kuhlmann T, Seif F et al. Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions. J Neuropathol Exp Neurol 2001 60 : 1087 1098.
15. Fearon U, Mullan R, Markham T et al. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Arthritis Rheum 2006 54 : 3152 3162.
16. Tsai CH, Huang FM, Chang YC. Immunohistochemical localization of oncostatin M in epithelialized apical periodontitis lesions. Int Endod J 2008 41 : 772 776.
17. Boniface K, Diveu C, Morel F et al. Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation. J Immunol 2007 178 : 4615 4622.
18. Yao L, Pan J, Setiadi H, Patel KD, McEver RP. Interleukin 4 or oncostatin M induces a prolonged increase in p-selectin mRNA and protein in human endothelial cells. J Exp Med 1996 184 : 81 92.
19. Brown TJ, Rowe JM, Liu JW, Shoyab M. Regulation of IL-6 expression by oncostatin M. J Immunol 1991 147 : 2175 2180.
20. Lu S, Wang H, Shi Y, Sun Y, Huang H, Dong M. Serum IL-16, not IL-15, was elevated in early second trimester of pregnancy in women who subsequently developed preeclampsia. Clin Chim Acta 2007 383 : 175 177.
21. Lambert-Messerlian GM, Silver HM, Petraglia F et al. Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy. J Soc Gynecol Investig 2000 7 : 170 174.
22. Pearson H. Reproductive immunology: Immunity's pregnant pause. Nature 2002 420 : 265 266.
23. Chen Q, Stone P, Ching LM, Chamley L. A role for interleukin-6 in spreading endothelial cell activation after phagocytosis of necrotic trophoblastic material: Implications for the pathogenesis of pre-eclampsia. J Pathol 2008 217 : 122 130.
24. Rega G, Kaun C, Demyanets S et al. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin M in human adipose tissue in vitro and in murine adipose tissue in vivo. Arterioscler Thromb Vasc Biol 2007 27 : 1587 1595.
25. Ong S, Lash G, Baker PN. Angiogenesis and placental growth in normal and compromised pregnancies. Baillieres Best Pract Res Clin Obstet Gynaecol 2000 14 : 969 980.
26. Kimura K, Hashiguchi T, Deguchi T et al. Serum VEGF-as a prognostic factor of atherosclerosis. Atherosclerosis 2007 194 : 182 188.